Skip to main content
Grivas P, Barata PC, Moon H, Hutson TE, Gupta S, Sternberg CN, Dave V, Downey C, Shillington AC, Devgan G, Kirker M, Thakkar S, Katzenstein HM, Bhanegaonkar A, Liu F, Brown J, Sonpavde GP. Baseline characteristics from a retrospective, observational, US-based, multicenter, real-world (RW) study of avelumab first-line maintenance (1LM) in locally advanced/metastatic urothelial carcinoma (la/mUC) (PATRIOT-II). Poster presented at the 2023 ASCO Genitourinary Cancers Symposium; February 16, 2023. San Francisco, CA. [abstract] J Clin Oncol. 2023 Feb 1; 41(Suppl 4). doi: 10.1200/JCO.2023.41.6_suppl.465
Grivas P, Barata PC, Moon H, Hutson TE, Gupta S, Sternberg CN, Pickard AS, Dave V, Han N, Shillington AC, Devgan G, Kim R, Thakkar S, Katzenstein H, Bhanegaonkar A, Liu F, Sonpavde GP. PATRIOT II: an ambispective, observational, multicenter, 2-cohort study of avelumab (Ave) first-line maintenance (1LM) in locally advanced/metastatic urothelial carcinoma (la/mUC) in the United States. Poster presented at the 2022 ASCO Annual Meeting; June 3, 2022. Chicago, IL. [abstract] J Clin Oncol. 2022 Jun 1; 40(Supple 6). doi: 10.1200/JCO.2022.40.6_suppl.TPS578 Journal of Clinical Oncology 40, no. 6_suppl
Apostolou A, Dave V, Jani N, Bolcen S, Lasker BA, Tan CG, Montana B, Genese CA. Nocardia cyriacigeorgica infections associated with cosmetic injections, New Jersey, 2010. Poster presented at the 2010 48th Annual Meeting Infectious Disease Society of America (IDSA); October 22, 2010. Vancouver, Canada.